MK-8351

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8351, covering 2015-07-16 to 2015-07-16. Get the full timeline:

Most recent: Clinical Trial Update: A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003) [Phase 1]